European Journal of Pediatrics

, 168:919

Noonan syndrome caused by germline KRAS mutation in Taiwan: report of two patients and a review of the literature

  • Fu-Sung Lo
  • Ju-Li Lin
  • Min-Tzu Kuo
  • Pao-Chin Chiu
  • San-Ging Shu
  • Mei-Chyn Chao
  • Yann-Jinn Lee
  • Shuan-Pei Lin
Original Paper

Abstract

Noonan syndrome is a highly variable disorder that has significant phenotypic overlap with Costello syndrome and cardio-facio-cutaneous syndrome. KRAS mutation was the second reported gene for Noonan syndrome. This study screened for mutation of the KRAS gene in 57 unrelated ethnic Chinese children suffering from Noonan syndrome without PTPN11 gene mutation in Taiwan. This work only identified two patients with different missense mutations (c.40G>A, p.Val14Ile; c.108A>G, p.Ile36Met) in the exon 1 of KRAS gene. This study also analyzed the characteristics of 34 reported cases involving KRAS mutations in the literature. All these patients presented with variable phenotypes, including Noonan syndrome (n = 19), cardio-facio-cutaneous syndrome (n = 7), Costello syndrome (n = 6), and Noonan/cardio-facio-cutaneous syndrome (n = 1). The phenotype of KRAS mutations was generally severe, including short stature, mental retardation, heart defects, etc. In conclusion, this investigation demonstrates that KRAS mutations are the cause in a minority of cases of Chinese patients with Noonan syndrome in Taiwan.

Keywords

Noonan syndrome KRAS Mutation analysis Cardio-facio-cutaneous syndrome Costello syndrome 

Abbreviations

NS

Noonan syndrome

CFC

Cardio-facio-cutaneous syndrome

CS

Costello syndrome

References

  1. 1.
    Aoki Y, Niihori T, Kawame H et al (2005) Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nature Genet 37:1038–1040PubMedCrossRefGoogle Scholar
  2. 2.
    Bertola DR, Pereira AC, Brasil AS et al (2007) Further evidence of genetic heterogeneity in Costello syndrome: involvement of the KRAS gene. J Hum Genet 52:521–526PubMedCrossRefGoogle Scholar
  3. 3.
    Carta C, Pantaleoni F, Bocchinfuso G et al (2006) Germline missense mutations affecting KRAS isoform B are associated with a severe Noonan syndrome phenotype. Am J Hum Genet 79:129–135PubMedCrossRefGoogle Scholar
  4. 4.
    Denayer E, Legius E (2007) What’s new in the neuro-cardio-facial-cutaneous syndromes. Eur J Pediatr 166:1091–1098PubMedCrossRefGoogle Scholar
  5. 5.
    Fryssira H, Leventopoulos G, Psoni S et al (2008) Tumor development in three patients with Noonan syndrome. Eur J Pediatr 167(9):1025–1031PubMedCrossRefGoogle Scholar
  6. 6.
    Hung CS, Lin JL, Lee YJ et al (2007) Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome. J Formos Med Assoc 106:169–172PubMedCrossRefGoogle Scholar
  7. 7.
    Kratz CP, Niemeyer CM, Zenker M (2007) An unexpected new role of mutant Ras: perturbation of human embryonic development. J Mol Med 85:227–235PubMedCrossRefGoogle Scholar
  8. 8.
    Nava C, Hanna N, Michot C et al (2007) Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signaling pathway: genotype–phenotype relationships and overlap with Costello syndrome. J Med Genet 44:763–771PubMedCrossRefGoogle Scholar
  9. 9.
    Niihori T, Aoki Y, Narumi Y et al (2006) Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome. Nature Genet 38:294–296PubMedCrossRefGoogle Scholar
  10. 10.
    Pandit B, Sarkozy A, Pennacchio LA et al (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39:1007–1012PubMedCrossRefGoogle Scholar
  11. 11.
    Razaque MA, Nishizawa T, Komoike Y et al (2007) Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat Genet 39:1013–1017CrossRefGoogle Scholar
  12. 12.
    Roberts AE, Araki T, Swanson KD et al (2007) Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 39:70–74PubMedCrossRefGoogle Scholar
  13. 13.
    Rodriguez-Viciana P, Tetsu O, Tidyman WE et al (2006) Germline mutations in genes within the MAPK pathway cause cardiofacio-cutaneous syndrome. Science 311(5765):1287–1290PubMedCrossRefGoogle Scholar
  14. 14.
    Schubbert S, Zenker M, Rowe SL et al (2006) Germline KRAS mutations cause Noonan syndrome. Nat Genet 38:331–336PubMedCrossRefGoogle Scholar
  15. 15.
    Søvik O, Schubbert S, Houge G et al (2007) De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. J Med Genet 44:e84–e89PubMedCrossRefGoogle Scholar
  16. 16.
    Tartaglia M, Mehler EL, Goldberg R et al (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465–468PubMedCrossRefGoogle Scholar
  17. 17.
    Zenker M, Buheitel G, Rauch R et al (2004) Genotype–phenotype correlations in Noonan syndrome. J Pediatr 144:368–374PubMedCrossRefGoogle Scholar
  18. 18.
    Zenker M, Lehman K, Schulz AL et al (2007) Expansion of the genotype and phenotypic spectrum in patients with KRAS germline mutations. J Med Genet 44:131–135PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Fu-Sung Lo
    • 1
  • Ju-Li Lin
    • 1
  • Min-Tzu Kuo
    • 1
  • Pao-Chin Chiu
    • 2
  • San-Ging Shu
    • 3
  • Mei-Chyn Chao
    • 4
  • Yann-Jinn Lee
    • 5
  • Shuan-Pei Lin
    • 5
  1. 1.Division of Pediatric Endocrinology, Department of Pediatrics, Chang Gung Memorial HospitalChung Gung University College of MedicineTaoyuanTaiwan
  2. 2.Department of PediatricsKaohsiung Veterans General HospitalKaohsiungTaiwan
  3. 3.Department of PediatricsTaichung Veterans General HospitalTaichungTaiwan
  4. 4.Department of PediatricsKaoshiung Medical University HospitalKaoshiungTaiwan
  5. 5.Departments of PediatricsMackay Memorial HospitalTaipeiTaiwan

Personalised recommendations